EYETECH PHARMACEUTICALS INC 4
4 · EYETECH PHARMACEUTICALS INC · Filed Aug 1, 2005
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2005-08-01$1.36/sh+1,850$2,516→ 44,945 total - Sale
Common Stock
2005-08-01$11.35/sh−1,850$20,998→ 43,095 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-08-01−1,850→ 115,921 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2005-08-01−1,850→ 60,479 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying)
Footnotes (1)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.